We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$542B
AUM Growth
+$18.5B
Cap. Flow
+$17.7B
Cap. Flow %
3.26%
Top 10 Hldgs %
22.88%
Holding
3,563
New
62
Increased
2,296
Reduced
842
Closed
70

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$793M
2
MSFT icon
Microsoft
MSFT
+$777M
3
KO icon
Coca-Cola
KO
+$755M
4
AAPL icon
Apple
AAPL
+$744M
5
NVDA icon
NVIDIA
NVDA
+$718M

Sector Composition

Rank Sector Weight
1 Technology 23.59%
2 Financials 12.77%
3 Consumer Discretionary 9.88%
4 Healthcare 9.85%
5 Industrials 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STI icon
3401
Solidion Technology
STI
$53.5M
$97.4K ﹤0.01%
2,795
+1,585
+131% +$32.9K
OPAD icon
3402
Offerpad Solutions
OPAD
$18.3M
$96.4K ﹤0.01%
3,384
WNEB icon
3403
Western New England Bancorp
WNEB
$259M
$95.2K ﹤0.01%
10,349
DTI icon
3404
Drilling Tools International
DTI
$82.6M
$92.5K ﹤0.01%
28,283
ATNM icon
3405
Actinium Pharmaceuticals
ATNM
$26.3M
$90.8K ﹤0.01%
72,093
CAMP icon
3406
CAMP4 Therapeutics
CAMP
$179M
$87.1K ﹤0.01%
+16,685
New +$137K
LPTH icon
3407
Lightpath Technologies
LPTH
$651M
$85.3K ﹤0.01%
24,173
GALT icon
3408
Galectin Therapeutics
GALT
$196M
$83.9K ﹤0.01%
65,073
BW icon
3409
Babcock & Wilcox
BW
$1.39B
$83.9K ﹤0.01%
+51,145
New +$108K
ZVIA icon
3410
Zevia
ZVIA
$122M
$83.8K ﹤0.01%
20,011
IVVD icon
3411
Invivyd
IVVD
$158M
$82.7K ﹤0.01%
186,680
-24,069
-11% -$18.7K
ACRS icon
3412
Aclaris Therapeutics
ACRS
$726M
$82K ﹤0.01%
+33,079
New +$82.3K
JBIO
3413
Jade Biosciences
JBIO
$1.2B
$77.8K ﹤0.01%
839
ORGN
3414
DELISTED
Origin Materials
ORGN
$76.8K ﹤0.01%
2,000
SBDS
3415
DELISTED
Solo Brands Inc
SBDS
$76.3K ﹤0.01%
1,672
LDI icon
3416
loanDepot
LDI
$532M
$75.4K ﹤0.01%
36,984
RSSS icon
3417
Research Solutions
RSSS
$73.6M
$75K ﹤0.01%
18,069
PHX
3418
DELISTED
PHX Minerals
PHX
$74.3K ﹤0.01%
18,580
UHG
3419
DELISTED
United Homes Group
UHG
$73.6K ﹤0.01%
17,396
DMAC icon
3420
DiaMedica Therapeutics
DMAC
$342M
$72K ﹤0.01%
13,251
PFIE
3421
DELISTED
Profire Energy, Inc
PFIE
$70.3K ﹤0.01%
27,669
ELEV
3422
DELISTED
Elevation Oncology
ELEV
$69.9K ﹤0.01%
124,181
VTGN icon
3423
VistaGen Therapeutics
VTGN
$9.89M
$68.7K ﹤0.01%
23,302
OTLK icon
3424
Outlook Therapeutics
OTLK
$183M
$68.1K ﹤0.01%
36,048
-15,411
-30% -$63.4K
BCOV
3425
DELISTED
Brightcove, Inc.
BCOV
$67.6K ﹤0.01%
15,530

Similar funds

Charles Schwab's Q4 2024 Portfolio in Review

As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.

  • Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
  • Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
  • Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
  • Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
  • Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
  • Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
  • Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.

Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.